English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
The Medicines Company
Nicholas Gueguen
| Aug 22, 2017
The Medicines Company releases progress report for second quarter
Nicholas Gueguen
| Jul 22, 2017
ORION-1 Phase II data shows promise for inclisiran
Caitlin Nordahl
| Apr 22, 2017
The Medicines Company to highlight its antimicrobial products at conference in Austria
Gene Johnson
| Apr 10, 2017
Medicines Co. webcast highlights clinical trial results of cholesterol-lowering drug
Kyle Perrotti
| Mar 15, 2017
Conference call to review study of inclisiran
Gene Johnson
| Mar 10, 2017
FDA accepts The Medicines Co.'s filing for urinary tract infection drug
Erianne Leatherman
| Mar 3, 2017
FDA accepts priority application for urinary tract infection treatment
Keri Carbaugh
| Jan 10, 2017
Meanwell presents at Morgan Healthcare Conference
Trending
+
Pharmaceuticals
Patient Daily
| Jul 22, 2025
Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily
| Jul 24, 2025
Long School of Medicine is largest physician trainer in South Texas
Patient Daily
| Jul 25, 2025
Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily
| Jul 25, 2025
Balloon sinuplasty marks 20 years since FDA approval
